Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 39,407.0 | 38,469.0 | 37,925.0 | 39,350.0 | 36,193.0 | 30,973.0 | 30,561.0 | 31,781.0 |
Revenue growth | 2.4% | 1.4% | -3.6% | 8.7% | 16.9% | 1.3% | -3.8% | 3.0% |
Cost of goods sold | 32,785.0 | 32,061.0 | 31,600.0 | 32,363.0 | 29,536.0 | 24,731.0 | -24,896.0 | 25,549.0 |
Gross profit | 6,622.0 | 6,408.0 | 6,325.0 | 6,987.0 | 6,657.0 | 6,242.0 | 55,457.0 | 6,232.0 |
Gross margin | 16.8% | 16.7% | 16.7% | 17.8% | 18.4% | 20.2% | 181.5% | 19.6% |
Selling, general and administrative | | | | | | | | |
General and administrative | 2,411.0 | 2,245.0 | 2,192.0 | 2,417.0 | 2,263.0 | 2,006.0 | 1,921.0 | 1,937.0 |
EBITA | 4,413.0 | 4,389.0 | 4,394.0 | 4,847.0 | 4,664.0 | 4,315.0 | 3,832.0 | 4,411.0 |
EBITA margin | 11.2% | 11.4% | 11.6% | 12.3% | 12.9% | 13.9% | 12.5% | 13.9% |
Amortization of intangibles | 202.0 | 226.0 | 261.0 | 277.0 | 270.0 | 79.0 | 88.0 | 116.0 |
EBIT | 4,211.0 | 4,163.0 | 4,133.0 | 4,570.0 | 4,394.0 | 4,236.0 | 3,744.0 | 4,295.0 |
EBIT margin | 10.7% | 10.8% | 10.9% | 11.6% | 12.1% | 13.7% | 12.3% | 13.5% |
Pre-tax income | 4,036.0 | 3,873.0 | 3,738.0 | 4,202.0 | 4,085.0 | 4,077.0 | 3,656.0 | 4,219.0 |
Income taxes | 646.0 | 616.0 | 571.0 | 718.0 | 727.0 | 1,165.0 | 977.0 | 1,183.0 |
Tax rate | 16.0% | 15.9% | 15.3% | 17.1% | 17.8% | 28.6% | 26.7% | 28.0% |
Earnings from continuing ops | 3,390.0 | 3,257.0 | 3,167.0 | 3,484.0 | 3,358.0 | 2,912.0 | 2,679.0 | 3,036.0 |
Earnings from discontinued ops | | | | | | | -107.0 | |
Net income | 3,390.0 | 3,257.0 | 3,167.0 | 3,484.0 | 3,345.0 | 2,912.0 | 2,572.0 | 3,036.0 |
Net margin | 8.6% | 8.5% | 8.4% | 8.9% | 9.2% | 9.4% | 8.4% | 9.6% |
|
Diluted EPS | $12.19 | $11.55 | $11.00 | $11.98 | $11.22 | $9.56 | $8.63 | $9.29 |
Shares outstanding (diluted) | 278.2 | 282.0 | 287.9 | 290.8 | 299.2 | 304.6 | 310.4 | 326.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|